A Multifaceted Evaluation of National Off-label Neurology Applications
Journal Title: Turkish Journal of Neurology - Year 2020, Vol 26, Issue 3
Abstract
Objective: Off-label drug use (OLDU) of neurologic diseases is approved by a regulatory authority, the Turkish Medicines and Medical Devices Agency (TMMDA) in Turkey. It was aimed to investigate the most common neurologic drugs relevant to off-label prescribing and the most prescribed diagnosis, demographic and medical characteristics of patients with OLDU applications in Turkey. Materials and Methods: Four years “TMMDA”s electronic OLDU application records, 9,758 applications in total, were evaluated retrospectively. Information regarding patients’ demographic characteristics, diagnoses, ordered drugs, and institutions were evaluated. Results: The most OLDU applications were mostly made in 2015, the majority of which were associated with neurodegenerative diseases. The mean age of the patients was 41.6 years and 65% were female. Some 62.1% of off-label drug application patients’ age range was found as 18-64 years. The most common applications were from the Marmara region with 36% and neurology clinics of university hospitals with 81%. Multiple sclerosis (MS) was the most common diagnosis and the most frequently used group of drugs was disease-modifying drugs used in the treatment of MS. Conclusion: Based on the four-year survey of OLDU applications for adult neurologic patients showed that unlicensed drug prescriptions were high. There are very few studies on the result of OLDU applications in neurology worldwide. We believe that this study will be a guide to neurologists with off-label application processes and the results in our country and will make a significant contribution to the literature.
Authors and Affiliations
Şükran Yurtoğulları, Hanife Rahmanlar, Ali Alkan, Banu Bayar, Hakkı Gürsöz, Nurten Uzun Adatepe
Keywords
Related Articles
- EP ID EP689426
- DOI 10.4274/tnd.2020.37791
- Views 155
- Downloads 0
Cerebral Venous Thrombosis Can Be Followed by Electroencephalography: Accompanied By a Case Discussion
no summary
Orolingual Angioedema After Intravenous Tissue Plasminogen Activator in a Patient with Insular Cortex Ischemia: A Case Report
Intravenous tissue plasminogen activator (tPA) increases survival rates without sequelae in acute ischemic stroke. Complications and management of this treatment have become more important with the increasing use of tPA....
Corticosteroid-responsive Epilepsia Partialis Continua
Epilepsia partialis continua (EPC) is a rare form of status epilepticus and often refractory to antiepileptic drugs (AEDs). Persistent seizure activity may increase pro-inflammatory biomarkers locally, which may respond...
Transvers Myelitis Due to HSV-2 Infection in an Undiagnosed HIV Positive Patient
Several disorders including inflammatory, ischemic, and metabolic can cause longitudinally extensive transverse myelopathy. HIV-associated spinal cord involvement is rare. It can be due to AIDS-associated myelopathy, or...
Evaluation of Sensory Nerve Conduction Studies and Hematologic Parameters in Restless Legs Syndrome
Objective: Restless legs syndrome (RLS) presents with sensory symptoms such as burning in the legs, patients want to move their legs. Symptoms become apparent at rest and at night. The aim of this study was to investigat...